Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 19, 2022
Toxicological evaluation of brominated vegetable oil in Sprague Dawley ratsK A Woodling, P Chitranshi, C C Jacob, et al.
Molecular Endocrinology (Baltimore, Md.)|April 1, 1997
Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cellsJ Tan, Y Sharief, K G Hamil, et al.
American Journal of Clinical Oncology|October 16, 1999
Phase II trial of a novel platinum analog, SKI 2053R, in patients with previously untreated extensive-stage small-cell lung cancerD Y Zang, K H Lee, J S Lee, et al.
Pharmacopsychiatry|August 6, 2015
Clozapine prescription and quality of life in Chinese patients with schizophrenia treated in primary careC-L Hou, M-Y Cai, X-R Ma, et al.
The Korean Journal of Internal Medicine|June 1, 1997
A randomized trial comparing cisplatin plus 5-fluorouracil with or without levamisole in operable gastric cancerJ S Choi, K H Lee, M J Ahn, et al.
British Journal of Cancer|July 31, 2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancerJ-L Lee, Y-K Kang, H J Kang, et al.
British Journal of Cancer|September 1, 2011
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortR Y Zang, P Harter, D S Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancerD Y Zang, B H Lee, H-C Park, et al.
British Journal of Cancer|March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)Y-K Kang, H-M Chang, J H Yook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)M-H Ryu, E Baba, K H Lee, et al.
Pageof 14